These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 2545579

  • 21. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
    Sweet CS, Gaul SL, Reitz PM, Blaine EH, Ribeiro LT.
    J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
    [Abstract] [Full Text] [Related]

  • 22. [Effects of single and repeated oral administration of MK-421 and captopril on blood pressures in normotensive and experimental hypertensive rats].
    Ohmura I, Maki E, Naruse T, Chen CS, Ikeda N, Asami T.
    Nihon Yakurigaku Zasshi; 1985 Oct; 86(4):293-302. PubMed ID: 3002925
    [Abstract] [Full Text] [Related]

  • 23. Hypotensive effect of SA446, an angiotensin converting enzyme inhibitor, in 2-kidney, 1-clip renal hypertensive and normotensive dogs.
    Nishimura K, Miyazaki M, Okunishi H, Toda N.
    Jpn J Pharmacol; 1987 Apr; 43(4):379-87. PubMed ID: 3039218
    [Abstract] [Full Text] [Related]

  • 24. Angiotensin converting enzyme inhibitors suppress the vascular renin-angiotensin system of spontaneously hypertensive rats.
    Higashimori K, Nakamaru M, Tabuchi Y, Nagano M, Mikami H, Ogihara T, Inagami T.
    Am J Hypertens; 1991 Jan; 4(1 Pt 2):56S-59S. PubMed ID: 2009150
    [Abstract] [Full Text] [Related]

  • 25. Antihypertensive profile of the angiotensin-converting enzyme inhibitors CI-906 and CI-907.
    Ryan MJ, Boucher DM, Cohen DM, Olszewski BJ, Singer RM, Smith RD, Kaplan HR.
    Fed Proc; 1984 Apr; 43(5):1330-2. PubMed ID: 6323224
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Angiotensin II suppression in humans by the orally active renin inhibitor Aliskiren (SPP100): comparison with enalapril.
    Nussberger J, Wuerzner G, Jensen C, Brunner HR.
    Hypertension; 2002 Jan; 39(1):E1-8. PubMed ID: 11799102
    [Abstract] [Full Text] [Related]

  • 28. The role of tissue renin-angiotensin systems in hypertension and effects of chronic converting-enzyme inhibition.
    Keuneke C, Yacullo R, Metzger R, Hellmann T, Peters J, Ganten D.
    Eur Heart J; 1990 May; 11 Suppl D():11-6. PubMed ID: 2163328
    [Abstract] [Full Text] [Related]

  • 29. Ceranapril (SQ 29,852), an orally active inhibitor of angiotensin converting enzyme (ACE).
    DeForrest JM, Waldron TL, Harvey C, Scalese R, Hammerstone S, Powell JR, Karanewsky D.
    J Cardiovasc Pharmacol; 1990 Jul; 16(1):121-7. PubMed ID: 1696654
    [Abstract] [Full Text] [Related]

  • 30. Different effects of captopril on blood pressure in the acute and chronic two-kidney Goldblatt hypertensive dogs.
    Ohara N, Ono H, Hashimoto K.
    Jpn Circ J; 1982 Jul; 46(7):706-14. PubMed ID: 7047789
    [Abstract] [Full Text] [Related]

  • 31. Angiotensin converting enzyme inhibition in heart, kidney, and serum studied ex vivo after administration of zofenopril, captopril, and lisinopril.
    Sun Y, Mendelsohn FA.
    J Cardiovasc Pharmacol; 1991 Oct; 18(4):478-86. PubMed ID: 1724523
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Onset of action of captopril, enalapril, enalaprilic acid and lisinopril in normal man.
    Semple PF, Cumming AM, Meredith PA, Morton JJ.
    Cardiovasc Drugs Ther; 1987 Oct; 1(1):45-50. PubMed ID: 2856460
    [Abstract] [Full Text] [Related]

  • 35. Role of the tissue renin-angiotensin system in the action of angiotensin-converting enzyme inhibitors.
    Tokita Y, Oda H, Franco-Saenz R, Mulrow PJ.
    Proc Soc Exp Biol Med; 1995 Apr; 208(4):391-6. PubMed ID: 7700888
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.
    Biollaz J, Schelling JL, Jacot Des Combes B, Brunner DB, Desponds G, Brunner HR, Ulm EH, Hichens M, Gomez HJ.
    Br J Clin Pharmacol; 1982 Sep; 14(3):363-8. PubMed ID: 6289859
    [Abstract] [Full Text] [Related]

  • 40. Pharmacological properties of FPL 63547, a novel inhibitor of angiotensin-converting enzyme.
    Carr RD, Higgs L, Killingback PG, Nicol AK, O'Connor SE, Robson A, Wells E, Simpson WT.
    Br J Pharmacol; 1990 May; 100(1):83-9. PubMed ID: 2164863
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.